A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma.

J Neurooncol · 2021 · PMC8279971 · PMID 34125374

Europe PMC DOI

hedged sentences

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

approached significancep = 0.051so close (0.05 < p ≤ 0.1)

For patients treated with TMZ alone, the average number of cycles was 13.2 (range 6–40), which approached significance when compared to combination therapy (p = 0.051).

also in 8,237 other papers

a strong trendno p-value reported

30.6 months), and there was a strong trend for additional benefit in patients harboring the 1p/19q co-deletion [ 4 ].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.